Marker Therapeutics MRKR
NASDAQ MRKR
$1.07 -0.06 (-5.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Change in Receivables (2011 - 2012)

Updated

Analysis

Marker Therapeutics (MRKR) Change in Receivables (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -188.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 1.37 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 333.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Marker Therapeutics 17.87 Mn -42.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 -24.00
Mar 31, 2012 24.00
Jun 30, 2011 -65.00
Mar 31, 2011 65.00
API Access

Marker Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=MRKR&period=max&api_key=YOUR_API_KEY